




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Financial
InstrumentDefinitionsA
financial
instrument
is
‘any
contract
that
gives
rise
toa
financial
asset
of
one
entity
and
a
financial
liability
orequity
instrument
of
another
entity’(IAS
32,
para11)A
financial
asset
is
any
asset
that
is:cashan
equity
instrument
of
another
entitya
contractual
right
to
receive
cash
or
anotherfinancial
asset
from
another
entitya
contractual
right
to
exchange
financialinstruments
with
another
entity
under
conditionsthat
are
potentially
favorable
to
the
entityA
financial
liability
is
any
liability
that
is
a:contractual
obligation
to
deliver
cash
or
another
financialasset
to
another
entitycontractual
obligation
to
exchange
financial
instruments
withanother
entity
under
conditions
that
are
potentiallyunfavorablea
non-derivative
contract
for
which
the
entity
is
or
may
beobliged
to
deliver
a
variable
numberof
the
entity's
ownequity
instruments.
(IAS
32,
para11)An
equity
instrument
is
‘any
contract
that
evidences
a
residualinterest
in
the
assets
of
an
entity
after
deducting
all
of
itsliabilities'(IAS
33,
para11)Reporting
standardsIAS
32
Financial
Instruments:
Presentation
deals
with
theclassification
of
financial
instruments
and
their
financialstatement
presentationIFRS
7
Financial
Instruments:
Discourses
deals
with
thedisclosure
of
financial
instruments
in
financial
statementsIFRS
9
Financial
Instruments
is
concerned
with
the
initialand
subsequent
measurement
of
financial
instruments1
Classification
of
financial
liabilities
and
equityIAS
32
clarifies
that
an
instrument
is
only
an
equityinstrument
if
in
the
definition
of
a
financial
liability
are
not
met.IAS
32
does
not
classify
a
financial
instrument
as
equity
orfinancial
liability
on
the
basis
of
its
legal
form
but
on
thesubstance
of
the
transaction.Ex14
million
preference
shares
for
$2.50
each.They
are
notmandatorily
redeemable.
A
dividend
is
payable
if,
and
only
if,dividends
are
paid
on
ordinary
shares.A
financial
liability
exists
if
there
is
an
obligation
to
deliver
cash
oranother
financial
asset.There
is
no
obligation
for
X
to
repay
the
instrument.
Dividends
areonly
payable
if
they
are
also
paid
on
ordinary
shares.There
is
no
obligation
to
pay
dividends
on
ordinary
shares
sothere
is
no
obligation
to
pay
dividends
on
these
preference
shares.The
instrument
is
not
a
financial
liability.
The
proceeds
from
thepreference
share
issue
should
therefore
be
classified
as
equity
in
thestatement
of
financial
position.Ex2X
issued
1
million
preference
shares
for
$3
each.
No
dividends
arepayable.
X
will
redeem
the
preference
shares
in
three
years’
timeby
issuing
ordinary
shares
worth
$3
million.
The
exact
numberof
ordinary
shares
issuable
will
be
based
on
their
fair
value
on
thedateX
will
redeem
the
preference
share
with
a
variable
number
ofordinary
shares
worth
$3
million.
Therefore,
the
preference
shareshould
be
classified
as
liability
in
the
statement
financial
position.Ex32
million
preference
shares
for
$2.80
each.
No
dividends
arepayable.
The
preference
shares
will
be
redeemed
in
two
years’time
by
issuing
3
million
ordinary
sharesX
will
redeem
the
preference
share
with
a
fixed
number
ofordinary
shares.
Therefore,
the
preference
share
should
beclassified
as
equity
in
the
statement
financial
position.Interest
&
dividendsDividends
paid
in
respect
of
preference
shares
classified
asa
liability
will
be
charged
as
a
finance
expense
throughprofit
or
lossDividends
paid
on
shares
classified
as
equity
will
bereported
in
the
statement
of
changes
in
equityOffsettingIAS
32
states
that
a
financial
asset
and
a
financial
liability
mayonly
be
offset
in
very
limited
circumstances.
The
net
amountmay
only
be
reported
when
the
entityhas
a
legally
enforceable
right
to
set
off
the
amountsintends
either
to
settle
on
a
net
basis,
or
to
realise
the
assetand
settle
the
liability
simultaneously"(IAS
32,
para
42)2
Recognition
and
measurement
of
financial
liabilitiesInitial
recognition
of
financial
liabilitiesAt
initial
recognition,
financial
liabilities
are
measured
at
fair
valueIf
the
financial
liability
will
be
held
at
fairvalue
through
profitor
loss,
transaction
costs
should
be
expensed
to
the
statement
ofprofit
or
lossIf
the
financial
liability
will
not
be
held
at
fair
value
throughprofit
or
loss,
transaction
costs
should
be
deducted
from
itscarrying
amountSubsequent
measurement
of
financial
liabilitiesThe
subsequent
treatment
of
a
financial
liability
is
that
they
can
bemeasured
at
either
:amortised
costfair
value
through
profit
or
lossAmortised
costThe
initial
carrying
amount
of
a
financial
liability
measured
atamortised
cost
is
its
fair
value
less
any
transaction
costs
(the
‘netproceeds’
from
issue).A
finance
cost
is
charged
on
the
liability
using
the
effective
rate
ofinterest.
This
will
increase
the
carrying
amount
of
the
liabilityDr
Finance
cost(P/L)Cr
LiabilityThe
liability
is
reduced
by
any
cash
payments
made
during
the
yearDr
LiabilityCr
CashIllustrationOn
1
January
20X1
X
issued
a
loan
note
with
a
$50,
000nominal
value.
It
was
issued
at
a
discount
of
16%
of
nominalvalue.
The
costs
of
issue
were
$2,
000.
Interest
of
5%
of
thenominal
value
is
payable
annually
in
arrears.
The
bond
mustbe
redeemed
on
1
January
20X6
(after
5years
)
at
a
premiumof
$4,611.The
effective
rate
of
interest
is
12%
per
yearRequired:How
will
this
be
reported
in
the
financial
statements
of
X
overthe
period
to
redemption?SolutionThe
liability
will
be
initially
recognised
at
the
net
proceeds
receivedface
value50,000Less:16%
discount(8,000)Less:
Issue
costs(2,000)Initial
recognition
of
liability40,000The
liability
is
then
measured
at
amortised
cost:YearOpeningbalanceFinance
cost
(Liability
x12%)Cash
payments($50,000x5%)Closing
balance140,0004,800(2,500)42,300242,3005,076(2,500)44,8763448765,385(2,500)47,761447,7615,731(2,500)50,992550,9926,119(2,500)54,61127,111(12,500)TO:
Profit
or
lossTo:
Statement
of
cashflowsTo:
SOFPFair
valuethrough
profit
of
lossOut
of
the
money
derivatives
and
liabilities
held
for
tradingare
measured
at
fair
value
through
profit
or
loss.IllustrationOn
1
January
20X1,
X
issued
a
financial
liability
for
itsnominal
value
of
$10
million.
Interest
is
payable
at
a
rate
of5%
in
arrears.
The
liability
is
repayable
on
31
December20X3.
X
trades
financial
liabilities
in
the
short-term.At
31
December
20X1,
market
rates
of
interest
have
risento
10%Required:Discuss
the
accounting
treatment
of
the
liability
at
31December
20X1SolutionThe
financial
liability
is
traded
in
the
short-term
and
so
is
measured
at
fair
value
through
profitor
loss.
The
liability
must
be
remeasured
to
fair
value
at
the
reporting
dateAssuming
that
the
fair
value
of
the
liability
cannot
be
observed
from
an
active
market,
it
can
becalculated
by
discounting
the
future
cash
flows
at
a
market
rate
of
interestDateCash
flow($m)Discount
ratePresentvalue($m)31/12/X20.51/1.10.4531/12X310.51/1.128.68
9.13
The
interest
payments
are
$10m
x
5%
=
$
0.
5mThe
fair
value
of
the
liability
at
the
year-end
is
$9.13
millionThe
following
adjustment
is
requiredDr
Liability
($10m-$9.13m)Cr
Profit
or
loss$
0.87m$
0.87mPilot
paperQ1
Issue
of
convertible
bondOn
1
October
20X5,
Hill
issued
a
convertible
bond
at
par
value
of
$20
million
and
has
recorded
it
as
a
non-current
liability.
Thebond
is
redeemable
for
cash
on
30
September
20X7
at
par.Bondholders
can
instead
opt
for
conversion
in
the
form
of
a
fixednumber
of
shares.
Interest
on
the
bond
is
payable
at
a
rate
of
4%a
year
in
arrears.
The
interest
paid
in
the
year
has
been
presentedin
finance
costs.
The
interest
rate
on
similar
debt
without
aconversion
option
is
10%.Discount
factorsYearDiscount
rate
4%Discount
rate
10%10·9620·90920·9250·8263
Compound
instrumentsRequirement
aI. Discuss,
with
suitable
calculations,
how
theconvertible
bond
should
be
dealt
with
in
theconsolidated
financial
statements
for
the
yearended
30
September
20X6,
showing
anyadjustments
required.
(6
marks)Hill
has
issued
a
compound
instrument
because
the
bond
hascharacteristics
of
both
a
financial
liability
(an
obligation
to
repay
cash)and
equity
(an
obligation
to
issue
a
fixed
number
of
Hill’s
own
shares).IAS
32
Financial
Instruments:
Presentation
specifies
that
compoundinstruments
must
be
split
into:a
liability
component
(the
obligation
to
repay
cash);an
equity
component
(the
obligation
to
issue
a
fixed
number
of
shares).The
split
of
the
liability
component
and
the
equity
component
at
the
issuedate
is
calculated
as
follows:the
liability
component
is
the
present
value
of
the
cash
repayments,
discounted
using
the
market
rate
on
non-convertible
bonds;the
equity
component
is
the
difference
between
the
cash
received
andthe
liability
component
at
the
issue
date.Answer(iii) -
Convertible
bondThe
initial
carrying
amount
of
the
liability
should
have
been
measured
at
$17·9million,
calculated
as
follows:DateCash
flow$mDiscount
ratePresent
value$m30
September
20X60·80·9090·7330
September
20X720·80·826
17·1817·91The
equity
component
should
have
been
initially
measured
at
$2·1
million($20m
–
$17·9m).The
adjustment
required
is:Dr
Non-current
liabilitiesCr
Equity$2·1m$2·1mThe
equity
component
remains
unchanged.
After
initial
recognition,
the
liability
is
measured
at
amortised
cost,
as
follows:1
October
20X5Finance
charge
(10%)Cash
paid30
September
20X6$m$m$m$m17·91·8(0·8)18·9The
finance
cost
recorded
for
the
year
was
$0·8
million
and
so
must
beincreased
by
$1·0
million
($1·8m
–
$0·8m).Dr
Finance
costsCr
Non-current
liabilities$1·0m$1·0mThe
liability
has
a
carrying
amount
of
$18·9
million
as
at
the
reportingdate.2019/12
Q2Preference
sharesOn
1
October
20X8,
the
CEO
and
finance
director
each
paid
$2mcash
in
exchange
for
preference
shares
from
Stent
Co
whichprovide
cumulative
dividends
of
7%
per
annum.
These
preferenceshares
can
either
be
converted
into
a
fixed
number
of
ordinary
shares
in
two
years’
time,
or
redeemed
at
par
on
the
same
date,
atthe
choice
of
the
holder.The
finance
director
suggests
to
the
accountant
that
the
preference
shares
should
be
classified
as
equity
because
the
conversion
isinto
a
fixed
number
of
ordinary
shares
on
a
fixed
date
(‘fixed
forfixed’)
and
conversion
is
certain
(given
the
current
market
valueof
the
ordinary
shares).
(4
marks)AnswerConvertible
redeemable
preference
sharesIAS
32
defines
an
equity
instrument
as
any
contract
whichevidences
a
residual
interest
in
the
assets
of
an
entity
afterdeducting
all
of
its
liabilities.An
equity
instrument
has
no
contractual
obligation
to
delivercash
or
another
financial
asset,
or
to
exchange
financial
assets
orfinancial
liabilities
under
potentially
unfavourable
conditions.If
settled
by
the
issuer’s
own
equity
instruments,
an
equityinstrument
has
no
contractual
obligation
to
deliver
a
variablenumber,
or
is
settled
only
by
exchanging
a
fixed
amount
of
cash
or
another
financial
asset
for
a
fixed
number
of
its
own
equity
instruments.Preference
shares
which
are
required
to
be
converted
into
a
fixed
numberof
ordinary
shares
on
a
fixed
date
should
be
classified
as
equity
(this
isknown
as
the
‘fixed
forfixed’
requirement
to
which
the
finance
directorrefers).However,
a
critical
feature
in
differentiating
a
financial
liability
from
anequity
instrument
is
the
existence
of
a
contractual
obligation
of
the
issuer
either
to
deliver
cash
or
another
financial
asset
to
the
holder,
or
toexchange
financial
assets
or
financial
liabilities
with
the
holder,
under
conditions
which
are
potentially
unfavourable
to
the
issuer.In
this
case,
Stent
Co
has
issued
convertible
redeemable
preferenceshares
–
which
makes
little
commercial
sense
from
the
company’sperspective,
as
they
offer
the
holder
the
benefit
of
conversion
intoordinary
shares
if
share
prices
rise,
and
the
security
of
redemption
(at
the
choice
of
the
holder)
if
share
prices
fall.IAS
32
notes
that
the
substance
of
a
financial
instrument,
ratherthan
its
legal
form,
governs
its
classification
in
the
entity’sstatement
of
financial
position.A
preference
share
which
provides
for
mandatory
redemption
for
afixed
or
determinable
amount
at
a
fixed
or
determinable
future
date
or
gives
the
holder
the
right
to
require
the
issuer
to
redeem
the
instrument
at
a
particular
date
for
a
fixed
or
determinableamount
is
a
financial
liability.Because
the
preference
shares
offer
the
holder
the
choice
ofconversion
into
ordinary
shares
as
well
as
redemption
in
two
years’time,
the
terms
of
the
financial
instrument
should
be
evaluated
todetermine
whether
it
contains
both
a
liability
and
an
equitycomponent.Such
components
are
classified
separately
as
compound
financialinstruments,
recognising
separately
the
components
of
a
financialinstrument
which
creates
both
a
financial
liability
of
the
entity
(acontractual
arrangement
to
deliver
cash
or
another
financial
asset)
andan
equity
instrument
(a
call
option
granting
the
holder
the
right,
for
aspecified
period
of
time,
to
convert
it
into
a
fixed
number
of
ordinaryshares
of
the
entity).In
accordance
with
IFRS
9
Financial
Instruments,
when
the
initialcarrying
amount
of
a
compound
financial
instrument
is
allocated
to
its
equity
and
liability
components,
the
equity
component
isassigned
the
residual
amount
after
deducting
from
the
fair
value
ofthe
instrument
as
a
whole
the
amount
separately
determined
for
theliability
component.Stent
Co
would
measure
the
fair
value
of
the
consideration
inrespect
of
the
liability
component
based
on
the
fair
value
of
asimilar
liability
without
any
associated
equity
conversion
option.The
equity
component
is
assigned
the
residual
amount.Gearing
would
decrease
if
the
draft
financial
statements
hadincluded
the
preference
shares
within
equity:
the
correction
wouldincrease
non-current
debt
(the
present
value
of
the
futureobligations)
and
decrease
equity.【MJ:整个题目,重要】4
DerivativeDerivative.
A
derivative
has
three
characteristics:its
value
changes
in
response
to
an
underlying
variable(e.g.
share
price
or
interest
rate)it
requires
little
or
no
initial
net
investmentit
is
settled
at
a
future
date.Eg:Forward
contract,
future,
optionEx
-
Forward
contractOn
1
November
20X1
Johnson
took
out
a
speculative
forwardcontract
to
buy
coffee
beans
for
delivery
on
30
April
20X2
atan
agreed
price
of
$6,000
intending
to
settle
net
in
cash.
Due
to
a
surge
in
expected
supply,
a
forward
contract
for
delivery
on30
April
20X2
would
have
cost
$5,000
on
31
December
20X1.RequiredDiscuss,
with
suitable
calculations,
how
the
above
financialinstruments
should
be
accounted
for
in
the
financial
statements
ofJohnson
for
the
year
ended
31
December
20X1.AnswerIFRS
9
applies
to
those
contracts
to
buy
orsell
a
non-financia
item
that
can
be
settled
net
in
cash
or
another
financial
instrument,or
by
exchanging
financial
instruments
as
if
the
contracts
wefinancial
instruments(IFRS
9:
para.
2.4).These
are
consideredfinancial
contractsThe
fair
value
of
a
forward
contract
at
inception
is
zero.The
fair
value
of
the
contract
at
the
year
end
is:$Market
price
of
forward
contract
at5,000-year
end
for
delivery
on
30
AprilJohnson's
forward
price(6,000)Loss(1,000)A
financial
liability
of
$1,000
is
therefore
recognised
with
acorresponding
charge
of
$1,000
to
profit
or
loss.5
Recognition
offinancialassetsInitial
recognition
of
financial
assetsIFRS
9
says
that
an
entity
should
recognise
a
financial
asset
'when,and
only
when,
the
entity
becomes
party
to
the
contractualprovisions
of
the
instrument'(IFRS
9,
para3.1.1)Financialcontracts
vs
executory
contractsIFRS
9
applies
to
those
contracts
to
buy
orsell
a
non-financia
item
that
can
be
settled
net
in
cash
or
another
financial
instrument,or
by
exchanging
financial
instruments
as
if
the
contracts
wefinancial
instruments(IFRS
9:
para.
2.4).These
are
consideredfinancial
contractsHowever,
contracts
that
were
entered
into
(and
continue
to
be
held)for
the
entity's
expecte
Purchase,
sale
orusage
requirements
ofnon-financial
items
are
outside
the
scope
of
IFRS
9.These
are
executory
contracts.
Executory
contracts
are
contractsunder
which
neither
party
has
performed
any
of
its
obligations
orboth
parties
have
partially
performed
their
obligations
to
an
equalextent)(IAS
37:
para.
3).Executory
contracts
are
not
initially
recognised
in
the
financialstatements
unless
they
are
onerous,
in
which
case
a
provision
isrequired.Gustoso
is
a
public
limited
company
which
produces
a
range
of
luxury
Italianfood
products
which
are
sold
to
restaurants,
shops
and
supermarkets.Wheat
contractGustoso
purchases
significant
quantities
of
wheat
for
use
in
its
bread
and
pastaproducts.
These
are
high-value
products
on
which
Gustoso
records
significantprofit
margins.
Nonetheless,
the
price
of
wheat
is
volatile
and
so,
on
1November
20X7,
Gustoso
entered
into
a
contract
with
a
supplier
to
purchase500,000
bushels
of
wheat
in
June
20X8
for
$5
a
bushel.
The
contract
can
besettled
net
in
cash.
Gustoso
has
entered
into
similar
contracts
in
the
past
andhas
always
taken
delivery
of
the
wheat.
By
31
December
20X7
the
price
ofwheat
had
fallen.
The
finance
director
recorded
a
derivative
liability
of
$0·5
million
on
the
statement
of
financial
position
and
a
loss
of
$0·5
million
in
the
statement
of
profit
or
loss.
Wheat
prices
may
rise
again
before
June
20X8.
Theaccountant
is
unsure
if
the
current
accounting
treatment
is
correct
but
feelsuncomfortable
approaching
the
finance
director
again.Pilot
paper
Q2IFRS
9
Financial
Instruments
applies
to
contracts
to
buy
or
sell
anon-financial
item
which
are
settled
net
in
cash.
Such
contracts
areusually
accounted
for
as
derivatives.However,
contracts
which
are
for
an
entity’s
‘own
use’
of
a
non-
financial
asset
are
exempt
from
the
requirements
of
IFRS
9.
Thecontract
will
qualify
as
‘own
use’
because
Gustoso
always
takesdelivery
of
the
wheat.
This
means
that
it
falls
outside
IFRS
9
andso
the
recognition
of
a
derivative
is
incorrect.Answer
-
ContractThe
contract
is
an
executory
contract.
Executory
contracts
arenot
initially
recognised
in
the
financial
statements
unless
theyare
onerous,
in
which
case
a
provision
is
required.
Thisparticular
contract
is
unlikely
to
be
onerous
because
wheatprices
may
rise
again.
Moreover,
the
finished
goods
which
thewheat
forms
a
part
of
will
be
sold
at
a
profit.
As
such,
noprovision
is
required.
The
contract
will
therefore
remainunrecognised
until
Gustoso
takes
delivery
of
the
wheat.The
derivative
liability
should
be
derecognised,
meaning
thatprofits
will
increase
by
$0·5
million.Subsequent
acquisition
of
20%
of
MachWhen
Kutchen
acquired
the
majority
,80%,
shareholding
in
Mach,there
was
an
option
on
the
remaining
20%
non-controlling
interest(NCI),
which
could
be
exercised
at
any
time
up
to
31
March
20X7.On
31
January
20X7,
Kutchen
acquired
the
remaining
NCI
in
Mach.The
payment
for
the
NCI
was
structured
so
that
it
contained
a
fixedinitial
payment
and
a
series
of
contingent
amounts
payable
over
the
following
two
years.Pilot
paper
Q1bThe
contingent
payments
were
to
be
based
on
the
future
profits
of
Mach
up
to
amaximum
amount.
Kutchen
felt
that
the
fixed
initial
payment
was
an
equitytransaction.
Additionally,
Kutchen
was
unsure
as
to
whether
the
contingent
payments
were
either
equity,
financial
liabilities
or
contingent
liabilities.After
a
board
discussion
which
contained
disagreement
as
to
the
accountingtreatment,
Kutchen
is
preparing
to
disclose
the
contingent
payments
inaccordance
with
IAS®
37
Provisions,
Contingent
Liabilities
and
ContingentAssets.
The
disclosure
will
include
the
estimated
timing
of
the
payments
andthe
directors’
estimate
of
the
amounts
to
be
settled.Requirement:
Advise
Kutchen
on
the
difference
between
equity
and
liabilities,
and
on
the
proposed
accounting
treatment
of
the
contingentpayments
on
the
subsequent
acquisition
of
20%
of
Mach.
(8marks)The
Framework
defines
a
liability
as
a
present
obligation,
arisingfrom
past
events
and
there
is
an
expected
outflow
of
economicbenefits.
IAS
32
Financial
Instruments:
Presentation
establishesprinciples
for
presenting
financial
instruments
as
liabilities
orequity.IAS
32
does
not
classify
a
financial
instrument
as
equity
or
financialliability
on
the
basis
of
its
legal
form
but
on
the
substance
of
thetransaction.The
key
feature
of
a
financial
liability
is
that
the
issuer
is
obliged
to
deliver
either
cash
or
another
financial
asset
to
the
holder.
Anobligation
may
arise
from
a
requirement
to
repay
principal
or
interestor
dividends.Answer
1bIn
contrast,
equity
has
a
residual
interest
in
the
entity’s
assets
afterdeducting
all
of
its
liabilities.An
equity
instrument
includes
no
obligation
to
deliver
cash
oranother
financial
asset
to
another
entity.A
contract
which
will
be
settled
by
the
entity
receiving
or
delivering
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 公寓共享茶室合同标准文本
- 火力发电厂环境保护与生态补偿考核试卷
- 专业医疗器械合同标准文本
- 加入健身俱乐部合同标准文本
- 劳动合同标准文本 广州
- 中夫妻房屋销售合同标准文本
- 中国1,8-萘酐行业市场竞争格局及发展趋向研判报告
- 2025中金汇通信技术有限公司甘肃分公司招聘60人笔试参考题库附带答案详解
- 2024重庆西永产业发展有限公司招聘7人笔试参考题库附带答案详解
- 酒店新媒体推广试题及答案
- 2024-2025学年北京市东城区五下数学期末检测试题含答案
- 2025年武汉铁路桥梁职业学院单招职业技能测试题库必考题
- 2025年河南女子职业学院单招职业技能测试题库参考答案
- 农网配电营业工(台区经理)技师考试题库
- 2025年度家暴离婚协议书范本制作与使用
- 课件:《鲁滨逊漂流记》
- 2025护理十大安全目标
- 2025年山西晋城市城区城市建设投资经营有限公司招聘笔试参考题库附带答案详解
- 《遗传疾病概述》课件
- GB/T 44980-2024冻虾滑
- 《医养结合事业发展探究的国内外文献综述》4400字
评论
0/150
提交评论